« Back to the previous page

OTC pharma R&D company in France

OTC pharma R&D company for sale  

• Size: small/tiny 
• Location of this manufacturer: Europe
• Sales: < 3m Euro
• #CFIE PHS028

Overview of this OTC pharma R&D company for sale 

A very attractive pharmaceutical company from France with a market potential of >1 billion US dollars. This company discovers, patents and sell its pharmaceutical products. Currently has 12 registered products on the market. Their products can be sold as OTC or as prescription products.

This company is currently seeking for partners which would:

Help to establish wide distribution network in pharmaceutical industry, OTC or hospitals.

Merger or acquire them.

License their innovative drugs.

 

Profile (strategy) of OTC pharma R&D company 

A French pharma company which was established 17 years ago and work as a R&D which supplies the market with ready-to-sell pharmaceutical products. 

Their products focuses on: topical anti-viral & MMP inhibitors, rhinosinusitis, bedsores & diabetic ulcers, throat infection, labial herpes, psoriasis, eczema, genital herpes & infection and oral mucositis. 

Some of the products have been launched in 9 countries. Between their partners belong: Sanofi, Siemens & C°, URGO, UPSA, Wochhardt.

In 2010 obtained EU marketing authorization. Their products can be sold as OTC (over the corner) or as prescription products.

Partnering strategy/collaborations :

This company is currently seeking for partners which would help to establish wide distribution network in pharmaceutical industry, OTC or hospitals, merger or acquire them or in - license their innovative drugs.

Investors who are interested in this company are welcomed to contact.

Activities and products of this OTC pharma R&D company for sale

Their products focuses on the treatment against topical anti-viral & MMP inhibitors, rhinosinusitis , bedsores & diabetic ulcers, throat infection, labial herpes,  psoriasis, eczema , genital herpes & infection and oral mucositis. 

Area where the company operates:

Pharma, Infectious and parasitic diseases, Neoplasms / cancer / oncology, Respiratory system, Skin and subcutaneous tissue, Genitourinary system, and Cosmetic. 

Highlights of OTC pharma R&D company  

• A very attractive pharmaceutical company from France with a market potential of >1 billion US dollars.
• This company has a ready to sell products that can be easily launch on the new market. 
• Some of the products have been launched in 9 countries. Between their partners belong: Sanofi, Siemens & C°, URGO, UPSA, Wochhardt.
• Is currently seeking for partners which would: help to establish wide distribution network in pharmaceutical industry, OTC or hospitals, merger, acquire or license their innovative drugs.

Information of this pharma R&D company   pharmaceutical distributor for sale

Feel free to contact us for more information regarding this OTC pharma R&D company for sale. If this OTC pharma R&D company  based in France does not fit your requirements, feel free to ask for other OTC pharma R&D company. For more buyers of pharmaceutical companies please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.